EN | TR
    E-ISSN: 2717-9206
    Current Medical Treatment of Severe Traumatic Brain Injury
    PDF
    Cite
    Share
    Request
    Letter to the Editor
    VOLUME: 5 ISSUE: 2
    P: 93-95
    August 2018

    Current Medical Treatment of Severe Traumatic Brain Injury

    J Pediatr Emerg Intensive Care Med 2018;5(2):93-95
    DOI: 10.4274/cayd.95867
    Osman Yeşilbaş
    1. Sağlık Bilimleri Üniversitesi, Van Eğitim ve Araştırma Hastanesi, Çocuk Yoğun Bakım Kliniği, Van, Türkiye
    No information available.
    No information available
    Received Date: 19.04.2018
    Accepted Date: 16.07.2018
    Publish Date: 03.08.2018
    PDF
    Cite
    Share
    Request

    References

    1
    Özçifçi G, Anıl AB, Zengin N, Kamit Can F, Arslan D, ve ark. Ağır Kafa Travmalı Bir Çocuk Olguda Başarılı Dekompresif Kraniektomi. J Pediatr Emerg Intensive Care Med. 2018;5:31-4.
    2
    Kochanek PM, Carney N, Adelson PD, Ashwal S, Bell MJ, Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. Pediatr Crit Care Med. 2012;13(Suppl 1):1-82.
    3
    Kukreti V, Mohseni-Bod H, Drake J. Management of raised intracranial pressure in children with traumatic brain injury. J Pediatr Neurosci. 2014;9:207-15.
    4
    Engorn B, Flerlage J. The Harrıet Lane Handbook. In: Lee CKK, Engorn B, Flerlage J, eds. Drug Dosages. 20th ed. Philadelphia, PA; 2015;845.
    5
    Perez CA, Figueroa SA. Complication Rates of 3% Hypertonic Saline Infusion Through Peripheral Intravenous Access. J Neurosci Nurs. 2017;49:191-5.
    6
    Dillon RC, Merchan C, Altshuler D, Papadopoulos J. Incidence of Adverse Events During Peripheral Administration of Sodium Chloride 3. J Intensive Care Med. 2018;33:48-53.
    7
    Jagannatha AT, Sriganesh K, Devi BI, Rao GS. An equiosmolar study on early intracranial physiology and long term outcome in severe traumatic brain injury comparing mannitol and hypertonic saline. J Clin Neurosci. 2016;27:68-73.
    8
    Mangat HS. Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury. Crit Care. 2018;22:37.
    9
    Shein SL, Ferguson NM, Kochanek PM, Bayir H, Clark RS, et al. Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury--Results From an Automated Data Collection System Time-Synched to Drug Administration. Pediatr Crit Care Med. 2016;17:236-45.
    10
    Alnemari AM, Krafcik BM, Mansour TR, Gaudin D. A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury. World Neurosurg. 2017;106:509-28.
    11
    Li M, Chen T, Chen SD, Cai J, Hu YH. Comparison of equimolar doses of mannitol and hypertonic saline for the treatment of elevated intracranial pressure after traumatic brain injury: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e736.
    12
    Asehnoune K, Lasocki S, Seguin P, Geeraerts T, Perrigault PF, et al. Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury - a multicentre prospective cohort study and systematic review. Crit Care. 2017;21:328.
    13
    Schomer KJ, Sebat CM, Adams JY, Duby JJ, Shahlaie K, Louie EL. Dexmedetomidine for Refractory Intracranial Hypertension. J Intensive Care Med. 2017:885066616689555.
    14
    Cohen L, Athaide V, Wickham ME, Doyle-Waters MM, Rose NG, Hohl CM. The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review. Ann Emerg Med. 2015;65:43-51.
    15
    Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014;21:163-73.
    16
    Khan SA, Bhatti SN, Khan AA, Khan Afridi EA, Muhammad G, et al. Comparison Of Efficacy Of Phenytoin And Levetiracetam For Prevention Of Early Post Traumatic Seizures. J Ayub Med Coll Abbottabad. 2016;28:455-60.
    17
    Wilson CD, Burks JD, Rodgers RB, Evans RM, Bakare AA, Safavi-Abbasi S. Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management. World Neurosurg. 2018;110:901-06.
    18
    Kochanek PM, Bramlett HM, Dixon CE, Dietrich WD, Mondello S, et al. Operation Brain Trauma Therapy: 2016 Update. Mil Med. 2018;183(suppl 1):303-12.
    19
    Caudle KL, Lu XC, Mountney A, Shear DA, Tortella FC. Neuroprotection and anti-seizure effects of levetiracetam in a rat model of penetrating ballistic-like brain injury. Restor Neurol Neurosci. 2016;34:257-70.
    20
    Xu JC, Shen J, Shao WZ, Tang LJ, Sun YZ, et al. The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis. Brain Inj. 2016;30:1054-61.
    21
    Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev. 2005;11:169-82.
    22
    He Z, Hu M, Zha YH, Li ZC, Zhao B, et al. Piracetam ameliorated oxygen and glucose deprivation-induced injury in rat cortical neurons via inhibition of oxidative stress, excitatory amino acids release and P53/Bax. Cell Mol Neurobiol. 2014;34:539-47.
    2024 ©️ Galenos Publishing House